GCO Genesco Inc

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

 

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarter Ended May 4, 2024

 

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to

Commission File No. 1-3083

Genesco Inc.

(Exact name of registrant as specified in its charter)

Tennessee			62-0211340
(State or other jurisdiction of incorporation or organization)			(I.R.S. Employer Identification No.)
	535 Marriott Drive		37214
Nashville,	Tennessee		(Zip Code)
(Address of principal executive offices)

 

Registrant's telephone number, including area code: (615) 367-7000

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $1.00 par value	GCO	New York Stock Exchange

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such report), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer; an accelerated filer; a non-accelerated filer; a smaller reporting company; or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

 

Large accelerated filer		☐		Accelerated filer	☒
Non-accelerated filer		☐		Smaller reporting company	☐
Emerging growth company		☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ☐ No ☒

As of May 31, 2024, there were 11,626,195 shares of the registrant's common stock outstanding.

---

INDEX

 

Part I. Financial Information
Item 1. Financial Statements:
Condensed Consolidated Balance Sheets - May 4, 2024, February 3, 2024 and April 29, 2023	4
Condensed Consolidated Statements of Operations - Three Months ended May 4, 2024 and April 29, 2023	5
Condensed Consolidated Statements of Comprehensive Loss - Three Months ended May 4, 2024 and April 29, 2023	6
Condensed Consolidated Statements of Cash Flows - Three Months ended May 4, 2024 and April 29, 2023	7
Condensed Consolidated Statements of Equity - Three Months ended May 4, 2024 and April 29, 2023	8
Notes to Condensed Consolidated Financial Statements	9
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations	14
Item 3. Quantitative and Qualitative Disclosures about Market Risk	19
Item 4. Controls and Procedures	19
Part II. Other Information	20
Item 1. Legal Proceedings	20
Item 1A. Risk Factors	20
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	20
Item 5. Other Information	20
Item 6. Exhibits	21
Signature	22

 

---

cautionary notice regarding forward-looking statements

Statements in this Quarterly Report on Form 10-Q include certain forward-looking statements, which include statements regarding our intent, belief or expectations and all statements other than those made solely with respect to historical fact. Actual results could differ materially from those reflected by the forward-looking statements in this Quarterly Report on Form 10-Q and a number of factors may adversely affect the forward-looking statements and our future results, liquidity, capital resources or prospects. These include, but are not limited to, adjustments to projections reflected in forward-looking statements, including those resulting from weakness in store and shopping mall traffic, restrictions on operations imposed by government entities and/or landlords, changes in public safety and health requirements and limitations on our ability to adequately staff and operate stores. Differences from expectations could also result from our ability to obtain from suppliers products that are in-demand on a timely basis and effectively manage disruptions in product supply or distribution, including disruptions as a result of pandemics or geopolitical events, including shipping disruptions in the Red Sea; the level of consumer spending on our merchandise and interest in our brands and in general; the level and timing of promotional activity necessary to maintain inventories at appropriate levels; our ability to pass on price increases to our customers; the timing and amount of any share repurchases by us; the imposition of tariffs on products imported by us or our vendors as well as the ability and costs to move production of products in response to tariffs; unfavorable trends in fuel costs, foreign exchange rates, foreign labor and material costs; a disruption in shipping or increase in cost of our imported products, and other factors affecting the cost of products; our dependence on third-party vendors and licensors for the products we sell; our ability to renew our license agreements; impacts of the Russia-Ukraine war, and other sources of market weakness in the U.K. and the Republic of Ireland; the effectiveness of our omni-channel initiatives; costs associated with changes in minimum wage and overtime requirements; wage pressure in the U.S. and the U.K.; labor shortages; the effects of inflation; the evolving regulatory landscape related to our use of social media; the establishment and protection of our intellectual property; weakness in the consumer economy and retail industry; competition and fashion trends in our markets, including trends with respect to the popularity of casual and dress footwear; any failure to increase sales at our existing stores, given our high fixed expense cost structure, and in our e-commerce businesses; risks related to the potential for terrorist events; store closures and effects on the business as a result of civil disturbances; changes in buying patterns by significant wholesale customers; changes in consumer preferences; our ability to continue to complete and integrate acquisitions; our ability to expand our business and diversify our product base; impairment of goodwill in connection with acquisitions; payment related risks that could increase our operating cost, expose us to fraud or theft, subject us to potential liability and disrupt our business; retained liabilities associated with divestitures of businesses including potential liabilities under leases as the prior tenant or as a guarantor of certain leases; and changes in the timing of holidays or in the onset of seasonal weather affecting period-to-period sales comparisons. Additional factors that could cause differences from expectations include the ability to secure allocations to refine product assortments to address consumer demand; the ability to renew leases in existing stores and control or lower occupancy costs, to open or close stores in the number and on the planned schedule, and to conduct required remodeling or refurbishment on schedule and at expected expense levels; our ability to realize anticipated cost savings, including rent savings; our ability to make our occupancy costs more variable, realize any anticipated tax benefits in both the amount and timeframe anticipated, and achieve expected digital gains and gain market share; deterioration in the performance of individual businesses or of our market value relative to our book value, resulting in impairments of fixed assets, operating lease right of use assets or intangible assets or other adverse financial consequences and the timing and amount of such impairments or other consequences; unexpected changes to the market for our shares or for the retail sector in general; our ability to meet our sustainability, stewardship, emission and diversity, equity and inclusion related ESG projections, goals and commitments; costs and reputational harm as a result of disruptions in our business or information technology systems either by security breaches and incidents or by potential problems associated with the implementation of new or upgraded systems, and the cost and outcome of litigation, investigations, disputes and environmental matters that involve us. For a full discussion of risk factors, see Item 1A, "Risk Factors".

Readers are cautioned not to place undue reliance on forward-looking statements as such statements speak only as of the date they were made and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. The most important factors which could cause our actual results to differ from our forward-looking statements are set forth in our description of risk factors in Item 1A contained in our Annual Report on Form 10-K for the fiscal year ended February 3, 2024 which should be read in conjunction with the forward-looking statements in this Quarterly Report on Form 10-Q. Forward-looking statements speak only as of the date they are made, and we do not undertake any obligation to update any forward-looking statement.

The events described in the forward-looking statements might not occur or might occur to a different extent or at a different time than we have described. As a result, our actual results may differ materially from the results contemplated by these forward-looking statements.

We maintain a website at www.genesco.com where investors and other interested parties may obtain, free of charge, press releases and other information as well as gain access to our periodic filings with the Securities and Exchange Commission (“SEC”). The information contained on this website should not be considered to be a part of this or any other report filed with or furnished to the SEC.

---

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements (unaudited)

 

Genesco Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

(In thousands, except share amounts)

 

Assets		May 4, 2024				February 3, 2024				April 29, 2023
Current Assets:
Cash		$	19,247			$	35,155			$	31,786
Accounts receivable, net of allowances of $2,545 at May 4, 2024,
$4,266 at February 3, 2024 and $4,051 at April 29, 2023			50,119				53,618				54,068
Inventories			392,671				378,967				470,763
Prepaids and other current assets			46,003				39,611				42,325
Total current assets			508,040				507,351				598,942
Property and equipment, net			233,601				240,266				239,120
Operating lease right of use assets			420,133				436,896				477,962
Non-current prepaid income taxes			57,441				56,839				54,567
Goodwill			9,417				9,565				37,928
Other intangibles			26,914				27,250				27,538
Deferred income taxes			26,119				26,230				28,729
Other noncurrent assets			25,752				25,493				30,526
Total Assets			1,307,417				1,329,890				1,495,312
Liabilities and Equity
Current Liabilities:
Accounts payable			108,847				114,621				143,814
Current portion - operating lease liabilities			125,450				129,189				131,830
Other accrued liabilities			73,888				75,727				75,992
Total current liabilities			308,185				319,537				351,636
Long-term debt			59,444				34,682				118,151
Long-term operating lease liabilities			345,670				359,073				399,374
Other long-term liabilities			45,665				45,396				43,526
Total liabilities			758,964				758,688				912,687
Commitments and contingent liabilities			—				—				—
Equity
Non-redeemable preferred stock			812				813				812
Common equity:
Common stock, $1 par value:
Authorized: 80,000,000 shares
Issued common stock			12,122				11,961				13,052
Additional paid-in capital			322,288				319,143				308,817
Retained earnings			271,647				296,766				318,538
Accumulated other comprehensive loss			(40,559	)			(39,624	)			(40,737	)
Treasury shares, at cost (488,464 shares)			(17,857	)			(17,857	)			(17,857	)
Total equity			548,453				571,202				582,625
Total Liabilities and Equity		$	1,307,417			$	1,329,890			$	1,495,312

 

The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.

---

Genesco Inc. and Subsidiaries

Condensed Consolidated Statements of Operations

(In thousands, except per share amounts)

 

 

			Three Months Ended
			May 4, 2024				April 29, 2023
Net sales			$	457,597			$	483,332
Cost of sales				241,316				254,524
Gross margin				216,281				228,808
Selling and administrative expenses				247,831				251,497
Asset impairments and other, net				578				308
Operating loss				(32,128	)			(22,997	)
Other components of net periodic benefit cost				109				92
Interest expense, net				890				1,651
Loss from continuing operations before income taxes				(33,127	)			(24,740	)
Income tax benefit				(8,839	)			(5,865	)
Loss from continuing operations				(24,288	)			(18,875	)
Loss from discontinued operations, net of tax				(59	)			(15	)
Net Loss			$	(24,347	)		$	(18,890	)
Basic loss per common share:
Continuing operations			$	(2.22	)		$	(1.60	)
Discontinued operations				(0.01	)			0.00
Net loss			$	(2.23	)		$	(1.60	)
Diluted loss per common share:
Continuing operations			$	(2.22	)		$	(1.60	)
Discontinued operations				(0.01	)			0.00
Net loss			$	(2.23	)		$	(1.60	)
Weighted average shares outstanding:
Basic				10,930				11,818
Diluted				10,930				11,818

 

The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.

---

Genesco Inc. and Subsidiaries

Condensed Consolidated Statements of Comprehensive Loss

(In thousands)

 

 

		Three Months Ended
		May 4, 2024				April 29, 2023
Net loss		$	(24,347	)		$	(18,890	)
Other comprehensive income (loss):
Postretirement liability adjustments, net of tax			38				29
Foreign currency translation adjustments			(973	)			445
Total other comprehensive income (loss)			(935	)			474
Comprehensive Loss		$	(25,282	)		$	(18,416	)

 

The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.

---

 

Genesco Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(In thousands)

 

		Three Months Ended
		May 4, 2024				April 29, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss		$	(24,347	)		$	(18,890	)
Adjustments to reconcile net loss to net cash used in
operating activities:
Depreciation and amortization			13,237				11,286
Deferred income taxes			399				16
Impairment of long-lived assets			244				308
Share-based compensation expense			3,307				3,772
Other			72				315
Changes in working capital and other assets and liabilities:
Accounts receivable			3,573				(13,367	)
Inventories			(14,466	)			(11,789	)
Prepaids and other current assets			(6,415	)			(16,364	)
Accounts payable			(5,816	)			359
Other accrued liabilities			(2,158	)			(4,843	)
Other assets and liabilities			(1,374	)			(11,248	)
Net cash used in operating activities			(33,744	)			(60,445	)
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures			(6,377	)			(17,235	)
Proceeds from asset sales			—				87
Net cash used in investing activities			(6,377	)			(17,148	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Borrowings under revolving credit facility			83,374				152,569
Payments on revolving credit facility			(58,573	)			(79,469	)
Shares repurchased related to share repurchase plan			—				(9,170	)
Shares repurchased related to taxes for share-based awards			(773	)			(449	)
Change in overdraft balances			214				(1,698	)
Net cash provided by financing activities			24,242				61,783
Effect of foreign exchange rate fluctuations on cash			(29	)			(394	)
Net decrease in cash			(15,908	)			(16,204	)
Cash at beginning of period			35,155				47,990
Cash at end of period		$	19,247			$	31,786
Supplemental information:
Interest paid		$	761			$	1,147
Income taxes paid			1,116				626

 

The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.

---

Genesco Inc. and Subsidiaries

Condensed Consolidated Statements of Equity

(In thousands)

 

	Non- Redeemable Preferred Stock			Common Stock			Additional Paid-In Capital			Retained Earnings			Accumulated Other Comprehensive Loss			Treasury Shares			Total Equity
Balance January 28, 2023	$	815		$	13,089		$	305,260		$	346,870		$	(41,211	)	$	(17,857	)	$	606,966
Net loss		—			—			—			(18,890	)		—			—			(18,890	)
Other comprehensive income		—			—			—			—			474			—			474
Share-based compensation expense		—			—			3,772			—			—			—			3,772
Restricted stock issuance		—			234			(234	)		—			—			—			—
Restricted shares withheld for taxes		—			(13	)		13			(449	)		—			—			(449	)
Shares repurchased		—			(255	)		—			(8,915	)		—			—			(9,170	)
Other		(3	)		(3	)		6			(78	)		—			—			(78	)
Balance April 29, 2023	$	812		$	13,052		$	308,817		$	318,538		$	(40,737	)	$	(17,857	)	$	582,625
	Non- Redeemable Preferred Stock			Common Stock			Additional Paid-In Capital			Retained Earnings			Accumulated Other Comprehensive Loss			Treasury Shares			Total Equity
Balance February 3, 2024	$	813		$	11,961		$	319,143		$	296,766		$	(39,624	)	$	(17,857	)	$	571,202
Net loss		—			—			—			(24,347	)		—			—			(24,347	)
Other comprehensive loss		—			—			—			—			(935	)		—			(935	)
Share-based compensation expense		—			—			3,307			—			—			—			3,307
Restricted stock issuance		—			198			(198	)		—			—			—			—
Restricted shares withheld for taxes		—			(29	)		29			(773	)		—			—			(773	)
Other		(1	)		(8	)		7			1			—			—			(1	)
Balance May 4, 2024	$	812		$	12,122		$	322,288		$	271,647		$	(40,559	)	$	(17,857	)	$	548,453

 

 

 

 

 

 

 

The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.

---

 

 

 

---

As of May 4, 2024, we have $0.7 million of long-lived assets held and used which were measured using Level 3 inputs within the fair value hierarchy. As of May 4, 2024, we have $6.5 million of investments held and used which were measured using Level 1 inputs within the fair value hierarchy.

 

 

 

---

 

 

As part of our Genesco Brands Group business, we have a commitment to Samsung C&T America, Inc. (“Samsung”) related to the ultimate sale and valuation of any inventories owned by Samsung. If product is sold below Samsung’s cost, we are required to pay to Samsung the difference between the sales price and its cost. At May 4, 2024, the inventory owned by Samsung had a historical cost of $7.8 million. As of May 4, 2024, we believe that we have appropriately accounted for any differences between the fair value of the Samsung inventory and Samsung's historical cost.

 

---

 

---

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

This section discusses management’s view of the financial condition, results of operations and cash flows of the Company. This section should be read in conjunction with the information contained in our Annual Report on Form 10-K for the fiscal year ended February 3, 2024, including the Risk Factors section, and information contained elsewhere in this Quarterly Report on Form 10-Q, including the Condensed Consolidated Financial Statements and notes to those financial statements. The results of operations for any interim period may not necessarily be indicative of the results that may be expected for any future interim period or the entire fiscal year.

Summary of Results of Operations

Our net sales decreased 5.3% to $457.6 million in the first quarter of Fiscal 2025 compared to $483.3 million in the first quarter of Fiscal 2024. The sales decrease compared to last year's first quarter was driven by a decline in store sales in all of our retail businesses, decreased wholesale sales primarily reflecting the repositioning of the Genesco Brands Group business to a more refined portfolio of licenses and the impact of net store closings, partially offset by a 3% increase in comparable e-commerce sales for the total Company and a $2.5 million favorable impact in sales due to changes in foreign exchange rates. Our sales for the first quarter of Fiscal 2025 included approximately $9.2 million due to moving a week of sales from the second quarter last year to the first quarter this year related to last year's 53-week calendar shift. The consumer environment remains choppy with consumers continuing to show a willingness to shop when there's a reason and shopping almost exclusively for key footwear items and brands. In addition, ongoing inflationary pressures continue to impact discretionary spending behavior. Journeys Group sales decreased 5%, Schuh Group sales decreased 1%, Johnston & Murphy Group sales decreased 4% and Genesco Brands Group sales decreased 25%, or an aggregate of $8.8 million for the first quarter of Fiscal 2025 compared to the first quarter of Fiscal 2024. Schuh's sales decreased 4% on a local currency basis for the first quarter of Fiscal 2025. Total comparable sales decreased 5% for the first quarter of Fiscal 2025, with same store sales down 7% and comparable e-commerce sales up 3%.

 

Gross margin decreased 5.5% to $216.3 million in the first quarter of Fiscal 2025 from $228.8 million in the first quarter of Fiscal 2024 and was flat as a percentage of net sales at 47.3% reflecting increased gross margin as a percentage of net sales in Journeys Group and Johnston & Murphy Group, partially offset by decreased gross margin as a percentage of net sales in Schuh Group and Genesco Brands Group. The flat gross margin as a percentage of net sales reflects lower markdowns at Journeys as a result of disciplined inventory management and a greater mix of direct-to-consumer sales, offset by decreased gross margin at Schuh reflecting product mix pressure and decreased gross margin at Genesco Brands reflecting a $1.6 million inventory provision for a distribution model transition.

Selling and administrative expenses in the first quarter of Fiscal 2025 decreased 1.5% to $247.8 million from $251.5 million compared to the first quarter of Fiscal 2024, reflecting the impact of our cost savings initiatives, including net store closures. Selling and administrative expenses increased as a percentage of net sales in the first quarter of Fiscal 2025 compared to the first quarter of Fiscal 2024 from 52.0% to 54.2%, reflecting increased expenses as a percentage of net sales in all of our operating business units except Genesco Brands Group. The overall increase in expenses as a percentage of net sales reflects the deleverage of expenses, especially occupancy expense, selling salaries, professional fees and depreciation expense, primarily as a result of decreased revenue in the first quarter of Fiscal 2025.

Operating margin was a loss of 7.0% in the first quarter of Fiscal 2025 compared to a loss of 4.8% in the first quarter of Fiscal 2024 reflecting decreased operating margin in all of our operating business units. The decrease in operating margin for the first quarter this year compared to the first quarter last year was impacted by decreased net sales and increased expenses as a percentage of net sales, while gross margin as a percentage of net sales remained flat.

The loss from continuing operations before income taxes (“pretax loss”) for the first quarter of Fiscal 2025 was $33.1 million compared to a pretax loss of $24.7 million for the first quarter of Fiscal 2024. The pretax loss for the first quarter of Fiscal 2025 included a $1.6 million charge for a distribution model transition in the Genesco Brands Group and asset impairment and other charges of $0.6 million for severance and asset impairments. The pretax loss for the first quarter of Fiscal 2024 included asset impairment and other charges of $0.3 million for asset impairments.

We had an effective income tax rate of 26.7% and 23.7% in the first quarter of Fiscal 2025 and Fiscal 2024, respectively. The higher tax rate for the first quarter this year compared to the first quarter last year reflects an increase in the applicable statutory tax rate in our U.K. jurisdiction from 24% to 25% and an increase in the amount of foreign losses for which we are unable to recognize a tax benefit.

The net loss in the first quarter of Fiscal 2025 was $24.3 million, or $2.23 diluted loss per share, compared to a net loss of $18.9 million, or $1.60 diluted loss per share, in the first quarter of Fiscal 2024.

Critical Accounting Estimates

We discuss our critical accounting estimates in Item 7, "Management’s Discussion and Analysis of Financial Condition and Results of Operations", in our Annual Report on Form 10-K for the fiscal year ended February 3, 2024. We describe our significant accounting policies in Note 1, "Summary of Significant Accounting Policies", of the Notes to Consolidated Financial Statements included in our Annual Report on

---

Form 10-K for the fiscal year ended February 3, 2024. There have been no other significant changes in our definition of significant accounting policies or critical accounting estimates since the end of Fiscal 2024.

Key Performance Indicators

In assessing the performance of our business, we consider a variety of performance and financial measures. The key performance indicators we use to evaluate the financial condition and operating performance of our business are comparable sales, net sales, gross margin, operating income and operating margin. These key performance indicators should not be considered superior to, as a substitute for or as an alternative to, and should be considered in conjunction with, the U.S. GAAP financial measures presented herein. These measures may not be comparable to similarly titled performance indicators used by other companies.

Comparable Sales

We consider comparable sales to be an important indicator of our current performance, and investors may find it useful as such. Comparable sales results are important to achieve leveraging of our costs, including occupancy, selling salaries, depreciation, etc. Comparable sales also have a direct impact on our total net revenue, cash and working capital. We define "comparable sales" as sales from stores open longer than one year, beginning with the first day a store has comparable sales (which we refer to as "same store sales"), and sales from websites operated longer than one year and direct mail catalog sales (which we refer to in this report as "comparable e-commerce sales"). Temporarily closed stores are excluded from the comparable sales calculation if closed for more than seven days. Expanded stores are excluded from the comparable sales calculation until the first day an expanded store has comparable prior year sales. Current year foreign exchange rates are applied to both current year and prior year comparable sales to achieve a consistent basis for comparison.

Results of Operations – First Quarter of Fiscal 2025 Compared to First Quarter of Fiscal 2024

 

Journeys Group

		Three Months Ended
		May 4, 2024				April 29, 2023				% Change
		(dollars in thousands)
Net sales		$	259,445			$	272,190				(4.7	)%
Operating loss		$	(18,822	)		$	(18,362	)			(2.5	)%
Operating margin			(7.3	)%			(6.7	)%

 

Net sales from Journeys Group decreased 4.7% to $259.4 million in the first quarter of Fiscal 2025, compared to $272.2 million in the first quarter of Fiscal 2024, primarily due to a total comparable sales decrease of 5% driven by decreased store sales, partially offset by increased e-commerce sales, and a 6% decrease in the average number of stores in the first quarter this year. We've experienced pressure on Journeys' core product assortment including boots and vulcanized product. We believe the Journeys consumer continues to be pressured by inflation and has chosen to conserve discretionary spending and primarily shop for key footwear items and brands. We closed 17 Journeys Group stores in the first quarter of Fiscal 2025 and continue to evaluate up to 50 Journeys store closures in Fiscal 2025. Journeys Group operated 1,047 stores at the end of the first quarter of Fiscal 2025, including 221 Journeys Kidz stores, 39 Journeys stores in Canada and 31 Little Burgundy stores in Canada, compared to 1,115 stores at the end of the first quarter of last year, including 232 Journeys Kidz stores, 42 Journeys stores in Canada and 34 Little Burgundy stores in Canada.

Journeys Group had an operating loss of $18.8 million in the first quarter of Fiscal 2025 compared to an operating loss of $18.4 million in the first quarter of Fiscal 2024. The increase in the operating loss for Journeys Group was due to (i) decreased net sales and (ii) increased selling and administrative expenses as a percentage of net sales reflecting the deleverage of expenses, especially occupancy expense, depreciation expense and selling salaries as a result of the decreased revenue in the first quarter of Fiscal 2025. In absolute dollars, selling and administrative expenses decreased 3.1%, which demonstrates the impact of our cost savings initiatives and closing underperforming stores. Gross margin as a percentage of net sales increased for the first quarter of Fiscal 2025, reflecting lower markdowns as a result of disciplined inventory management, partially offset by decreased initial mark-ons driven by a shift in brand mix.

 

---

Schuh Group

		Three Months Ended
		May 4, 2024				April 29, 2023				% Change
		(dollars in thousands)
Net sales		$	92,349			$	93,105				(0.8	)%
Operating loss		$	(5,896	)		$	(1,790	)			(229.4	)%
Operating margin			(6.4	)%			(1.9	)%

 

Net sales from Schuh Group decreased 0.8% to $92.3 million in the first quarter of Fiscal 2025 compared to $93.1 million in the first quarter of Fiscal 2024, primarily due to decreased total comparable sales of 7% driven by decreased store sales and e-commerce sales, partially offset by a favorable impact of $2.5 million due to changes in foreign exchange rates. Schuh continued to contend with a challenging U.K. macro environment in the first quarter this year and unseasonable weather to start the spring selling season. In addition, Schuh Group sales in the first quarter of Fiscal 2025 compares against strong sales growth in the first quarters of Fiscal 2024 and Fiscal 2023. Just like the Journeys consumer, the U.K. consumer is more discriminating and key-item focused in their purchases. Schuh's e-commerce business remains a key channel for consumer engagement, accounting for approximately 40% of its sales in the first quarter of Fiscal 2025. Schuh's sales decreased 4% on a local currency basis for the first quarter of Fiscal 2025. Schuh Group operated 122 stores at the end of the first quarter of Fiscal 2025, compared to 123 stores at the end of the first quarter of Fiscal 2024.

Schuh Group had an operating loss of $5.9 million in the first quarter of Fiscal 2025 compared to an operating loss of $1.8 million in the first quarter of Fiscal 2024. The $4.1 million increase in operating loss compared to last year reflects (i) decreased net sales, (ii) decreased gross margin as a percentage of net sales reflecting a brand mix shift and (iii) increased selling and administrative expenses as a percentage of net sales, reflecting increased marketing, depreciation and compensation expenses. In addition, the operating loss included an unfavorable impact of $0.2 million due to changes in foreign exchange rates compared to last year.

Johnston & Murphy Group

		Three Months Ended
		May 4, 2024				April 29, 2023				% Change
		(dollars in thousands)
Net sales		$	79,207			$	82,627				(4.1	)%
Operating income		$	2,355			$	4,806				(51.0	)%
Operating margin			3.0	%			5.8	%

 

Johnston & Murphy Group net sales decreased 4.1% to $79.2 million for the first quarter of Fiscal 2025 from $82.6 million for the first quarter of Fiscal 2024, primarily due to a 3% decrease in comparable sales, reflecting decreased store sales and e-commerce sales with the slower start to spring selling, and decreased wholesale sales as well as a 3% decrease in the average number of stores in the first quarter this year. In addition, Johnston & Murphy Group sales in the first quarter of Fiscal 2025 compares against strong sales growth in the first quarters of Fiscal 2024 and Fiscal 2023. Johnston & Murphy just launched its new marketing campaign, "Not Your Dad's Shoe Company" which continues to showcase the repositioning of the business to a more casual, modern lifestyle brand. The brand's apparel and accessories continued to resonate well with its consumers in the first quarter this year. Retail operations accounted for 74.0% of Johnston & Murphy Group's sales in the first quarter of Fiscal 2025, up from 72.9% in the first quarter of Fiscal 2024. The store count for Johnston & Murphy retail operations at the end of the first quarter of Fiscal 2025 was 152 stores, including five stores in Canada, compared to 158 stores, including six stores in Canada, at the end of the first quarter of Fiscal 2024.

Johnston & Murphy Group had operating income of $2.4 million for the first quarter of Fiscal 2025 compared to $4.8 million in the first quarter of Fiscal 2024. The decrease in operating income compared to last year reflects (i) decreased net sales and (ii) increased selling and administrative expenses as a percentage of net sales for the first quarter of Fiscal 2025, reflecting the deleverage of expenses, especially marketing expense, occupancy expense and selling salaries as a result of decreased revenue in the first quarter of Fiscal 2025, partially offset by decreased performance-based compensation. Gross margin as a percentage of net sales increased for the first quarter of Fiscal 2025, reflecting lower warehouse costs.

 

---

Genesco Brands Group

		Three Months Ended
		May 4, 2024				April 29, 2023				% Change
		(dollars in thousands)
Net sales		$	26,596			$	35,410				(24.9	)%
Operating loss		$	(986	)		$	(32	)		NM
Operating margin			(3.7	)%			(0.1	)%

 

Genesco Brands' net sales decreased 24.9% to $26.6 million for the first quarter of Fiscal 2025 from $35.4 million for the first quarter of Fiscal 2024 due primarily to the repositioning of the business to a more refined portfolio of licenses, partially offset by increased sales of Dockers footwear.

 

Genesco Brands' operating loss was $1.0 million in the first quarter of Fiscal 2025 compared to essentially breakeven in the first quarter of Fiscal 2024. The increased operating loss was primarily due to (i) decreased net sales and (ii) decreased gross margin as a percentage of net sales reflecting a $1.6 million inventory provision for a distribution model transition, partially offset by a brand sales mix shift. Selling and administrative expenses decreased as a percentage of net sales in the first quarter of Fiscal 2025 reflecting decreased royalty expense, bad debt expense, warehouse costs and marketing expenses, partially offset by increased performance-based compensation expense and compensation expense.

Corporate, Interest Expenses and Other Charges

Corporate and other expense for the first quarter of Fiscal 2025 was $8.8 million compared to $7.6 million for the first quarter of Fiscal 2024. Corporate expense in the first quarter of Fiscal 2025 included a $0.6 million charge in asset impairment and other charges for severance and asset impairments. Corporate expense in the first quarter of Fiscal 2024 included a $0.3 million charge in asset impairment and other charges for asset impairments. The corporate expense increase, excluding asset impairment and other charges, primarily reflects an increase in professional fees in the first quarter this year compared to the first quarter last year.

Net interest expense decreased 46.1% to $0.9 million in the first quarter of Fiscal 2025 compared to $1.7 million in the first quarter of Fiscal 2024 primarily reflecting decreased average borrowings in the first quarter this year compared to the first quarter last year.

Liquidity and Capital Resources

Working Capital

Our business is seasonal, with our investment in working capital normally reaching peaks in the summer and fall of each year in anticipation of the back-to-school and holiday selling seasons. Historically, cash flows from operations typically have been generated principally in the fourth quarter of each fiscal year.

 

		Three Months Ended
Cash flow changes:		May 4, 2024				April 29, 2023				Increase (Decrease)
(in thousands)
Net cash used in operating activities		$	(33,744	)		$	(60,445	)		$	26,701
Net cash used in investing activities			(6,377	)			(17,148	)			10,771
Net cash provided by financing activities			24,242				61,783				(37,541	)
Effect of foreign exchange rate fluctuations on cash			(29	)			(394	)			365
Net decrease in cash		$	(15,908	)		$	(16,204	)		$	296

 

Reasons for the major variances in cash provided by (used in) the table above are as follows:

Cash used in operating activities was $26.7 million lower in the first three months of Fiscal 2025 compared to the first three months of Fiscal 2024, reflecting primarily the following factors:

---

 

Cash used in investing activities was $10.8 million lower for the first three months of Fiscal 2025 as compared to the first three months of Fiscal 2024 reflecting decreased capital expenditures primarily related to investments in retail stores and omni-channel capabilities.

 

Cash provided by financing activities was $37.5 million lower in the first three months of Fiscal 2025 as compared to the first three months of Fiscal 2024 reflecting decreased net borrowings partially offset by decreased share repurchases this year compared to the same period last year.

Sources of Liquidity and Future Capital Needs

We have three principal sources of liquidity: cash flow from operations, cash on hand and our credit facilities discussed in Item 8, Note 8, "Long-Term Debt", to our Consolidated Financial Statements included in our Annual Report on Form 10-K for Fiscal 2024.

As of May 4, 2024, we have borrowed $56.3 million U.S. revolver borrowings and $3.1 million (C$4.3 million) related to GCO Canada ULC. We were in compliance with all the relevant terms and conditions of the Credit Facility and the Facility Agreement as of May 4, 2024.

We believe that cash on hand, cash provided by operations and borrowings under our Credit Facility and the Facility Agreement will be sufficient to support our liquidity needs in Fiscal 2025 and the foreseeable future.

In the fourth quarter of Fiscal 2021, we implemented tax strategies allowed under the 5-year carryback provisions in the CARES Act which we believe will generate approximately $55 million of net tax refunds. We received approximately $26 million of such net tax refunds in Fiscal 2022 and anticipated receipt of the remaining outstanding net tax refund in Fiscal 2023. However, in the third quarter of Fiscal 2023, we were notified the IRS would conduct an audit of the periods related to the outstanding net tax refund. While we do not believe any uncertainty with the technical merits of the positions generating the net tax refunds exists, we do anticipate the timing of the net tax refund will be extended as a result of the audit process. Accordingly, we have recorded the outstanding refund to non-current prepaid income taxes on the Condensed Consolidated Balance Sheets as of May 4, 2024.

Contractual Obligations

Our contractual obligations at May 4, 2024 increased 1% compared to February 3, 2024, primarily due to increased long-term debt, partially offset by decreased lease obligations and purchase obligations.

Capital Expenditures

Total capital expenditures in Fiscal 2025 are expected to be approximately $52 million to $57 million of which approximately 61% is for new stores and remodels and 39% is for computer hardware, software and warehouse enhancements for initiatives to drive traffic and omni-channel capabilities. We do not currently have any longer-term capital expenditures or other cash requirements other than as set forth above and in the contractual obligations table as disclosed in Item 7 of our Fiscal 2024 Form 10-K. We also do not currently have any off-balance sheet arrangements.

Common Stock Repurchases

We did not repurchase any shares during the first quarter of Fiscal 2025. We have $52.1 million remaining as of May 4, 2024 under our expanded share repurchase authorization announced in June 2023. We repurchased 255,000 shares during the first quarter of Fiscal 2024 at a cost of $9.2 million, or $35.96 per share. During the second quarter of Fiscal 2025, through June 12, 2024, we have repurchased 7,700 shares at a cost of $0.2 million, or $24.90 per share.

Environmental and Other Contingencies

We are subject to certain loss contingencies related to environmental proceedings and other legal matters, including those disclosed in Item 1, Note 7, "Legal Proceedings", to our Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q.

---

New Accounting Pronouncements

Descriptions of recently issued accounting pronouncements, if any, and the accounting pronouncements adopted by us during the first quarter of Fiscal 2025 are included in Note 1 to our Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

We incorporate by reference the information regarding market risk appearing in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” under the heading “Financial Market Risk” in our Annual Report on Form 10-K for the fiscal year ended February 3, 2024. There have been no material changes to our exposure to market risks from those disclosed in the Form 10-K.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We have established disclosure controls and procedures designed to ensure that information required to be disclosed by us, including our consolidated subsidiaries, in the reports we file or submit under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), is made known to the officers who certify our financial reports and to other members of senior management. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving desired objectives.

Based on their evaluation as of May 4, 2024, the principal executive officer and principal financial officer of the Company have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Exchange Act) were effective to ensure that the information required to be disclosed by us in the reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported within time periods specified in SEC rules and forms and (ii) accumulated and communicated to our management, including our principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during our first quarter of Fiscal 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

---

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

We incorporate by reference the information regarding legal proceedings in Item 1, Note 7, “Legal Proceedings”, to our Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q.

Item 1A. Risk Factors

You should carefully consider the risk factors discussed in Part I, “Item 1A. Risk Factors” in the Annual Report on Form 10-K for the fiscal year ended February 3, 2024, which could materially affect our business, financial condition or future results. The risks described in this report, and in our Annual Report are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

Repurchases (shown in thousands except share and per share amounts):

 

ISSUER PURCHASES OF EQUITY SECURITIES
Period		(a) Total Number of Shares Purchased				(b) Average Price Paid per Share				(c) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs				(d) Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs
February 2024
2-4-24 to 3-2-24(1)			—			$	—				—			$	52,109
March 2024
3-3-24 to 3-30-24(1)			—			$	—				—			$	52,109
3-3-24 to 3-30-24(2)			8,357			$	27.33
April 2024
3-31-24 to 5-4-24 (1)			—			$	—				—			$	52,109
3-31-24 to 5-4-24 (2)			20,730			$	26.27				—				—
Total			29,087			$	26.57				—			$	52,109
(1) Share repurchases were made pursuant to a $100.0 million share repurchase program approved by the Board of Directors and announced in February 2022, and in June 2023, the Board of Directors approved an additional $50.0 million for share repurchases. We expect to implement the balance of the repurchase program through purchases made from time to time either in the open market or through private transactions, in accordance with the regulations of the SEC and other applicable legal requirements.
(2) These shares represent shares withheld from vested restricted stock to satisfy the minimum withholding requirement for federal and state taxes.

 

Item 5. Other Information

 

(c) During the first quarter of Fiscal 2025, no director or Section 16 officer of the Company adopted or terminated any Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements (in each case, as defined in Item 408 (a) of Regulation S-K).

 

---

Item 6. Exhibits

 

Exhibit Index
(10.1)		Genesco Inc. Executive Severance Plan. Incorporated by reference to Exhibit (10.1) to the Current Report on Form 8-K filed on May 3, 2024 (File No. 1-3083).
(10.2)		Form of Genesco Inc. Performance Share Unit Agreement
(31.1)		Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
(31.2)		Certification of the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
(32.1)		Certification of the Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
(32.2)		Certification of the Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101		The following materials from Genesco Inc.'s Quarterly Report on Form 10-Q for the quarter ended May 4, 2024, formatted in Inline XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets at May 4, 2024, February 3, 2024 and April 29, 2023, (ii) Condensed Consolidated Statements of Operations for each of the three months ended May 4, 2024 and April 29, 2023, (iii) Condensed Consolidated Statements of Comprehensive Loss for each of the three months ended May 4, 2024 and April 29, 2023, (iv) Condensed Consolidated Statements of Cash Flows for each of the three months ended May 4, 2024 and April 29, 2023, (v) Condensed Consolidated Statements of Equity for each of the three months ended May 4, 2024 and April 29, 2023, and (vi) Notes to the Condensed Consolidated Financial Statements.
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

---

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

	Genesco Inc.
	By:			/s/ Thomas A. George
				Thomas A. George
				Senior Vice President - Finance and Chief Financial Officer

 

Date: June 13, 2024

 

---

FORM OF Genesco Inc.

PERFORMANCE SHARE UNIT AGREEMENT

This PERFORMANCE SHARE UNIT AGREEMENT (this “Agreement”) is made and entered into as of the ____day of _________, 20__ (the “Grant Date”), between Genesco Inc., a Tennessee corporation (together with its Subsidiaries and Successors, the “Company”), and [Participant Name], (the “Grantee”). Capitalized terms not otherwise defined herein shall have the meaning ascribed to such terms in the Genesco Inc. Amended and Restated 2020 Equity Incentive Plan, as may be amended and restated from time to time (the “Plan”).

WHEREAS, the Company has adopted the Plan, which permits the issuance of Performance Awards, including Restricted Share Units that provide the right to receive Shares upon the attainment of performance objectives and other vesting conditions (each, a “Performance Share Unit”); and

WHEREAS, the Committee has determined that the Grantee is entitled to an Award of Performance Share Units under the Plan on the terms and conditions set forth herein.

NOW, THEREFORE, the parties hereto agree as follows:

PERFORMANCE SHARE UNIT GRANT

Grantee:		[Participant Name] [Participant Address]
Target Number of Performance Share Units Granted Hereunder (“Target Award”):		[Award]
Grant Date:		[Grant Date]

---

---

---

At the time of any payment of dividends to stockholders on Shares, the PSUs will be credited with additional Performance Share Units (the “Dividend Equivalent Units”) (including fractional units) for cash dividends paid on Shares by (a) multiplying the cash dividend paid per Share by the number of PSUs (and previously credited Dividend Equivalent Units) outstanding and unpaid, and (b) dividing the product determined above by the Fair Market Value of a Share, in each case, on the dividend record date. The PSUs will be credited with Dividend Equivalent Units for stock dividends paid on Shares by multiplying the stock dividend paid per Share by the number of PSUs equal to the Target Award (and previously credited Dividend Equivalent Units) outstanding and unpaid on the dividend record date. Each Dividend Equivalent Unit shall have a value equal to one Share. Any Dividend Equivalent Unit will be subject to the same vesting, payment and other terms and conditions and restrictions as the PSUs to which the Dividend Equivalent Unit relates. For the avoidance of doubt, no Dividend Equivalent Units shall accrue under this Section 3 in the event that any Dividend Equivalent Units or other applicable adjustments pursuant to Section 5 hereof provide similar benefits.

Nothing in this Agreement or the Plan shall be interpreted or construed to confer upon the Grantee any right to continue service as an officer or employee of the Company.

---

The provisions of Section 4.2 (Adjustments) and Section 13 (Change in Control) of the Plan are hereby incorporated by reference, and the PSUs (and any Dividend Equivalent Units) are subject to such provisions. Any determination made by the Committee or the Board pursuant to such provisions shall be made in accordance with the provisions of the Plan and shall be final and binding for all purposes of the Plan and this Agreement.

The Grantee hereby acknowledges receipt of a copy of the Plan and agrees to be bound by all the terms and provisions thereof. The terms of this Agreement are governed by the terms of the Plan, and in the case of any inconsistency between the terms of this Agreement and the terms of the Plan, the terms of the Plan shall govern. The Committee shall have the power to interpret the Plan and this Agreement and to adopt such rules for the administration, interpretation and application of the Plan as are consistent therewith and to interpret or revoke any such rules. All actions taken and all interpretations and determinations made by the Committee shall be final and binding upon the Grantee, the Company and all other interested persons. No member of the Committee shall be personally liable for any action, determination or interpretation made in good faith with respect to the Plan or this Award.

Subject to applicable restrictions provided in the Plan, the Committee may waive any conditions or rights under, amend any terms of, or alter, suspend, discontinue, cancel or terminate, the Award, prospectively or retroactively; provided that any such waiver, amendment, alteration, suspension, discontinuance, cancellation or termination that would adversely affect the rights of the Grantee or any holder or beneficiary of the Award in more than a de minimis way shall not to that extent be effective without the consent of the Grantee, holder or beneficiary affected.

Notwithstanding anything herein to the contrary, to the maximum extent permitted by applicable law, the settlement of the PSUs (including any Dividend Equivalent Units related thereto) to be made to the Grantee pursuant to this Agreement is intended to qualify as a “short-term deferral” pursuant to Section 1.409A-1(b)(4) of the U.S. Treasury Regulations and this Agreement shall be interpreted consistently therewith. However, under certain circumstances, settlement of the PSUs or any Dividend Equivalent Units may not so qualify, and in that case, the Committee shall administer the grant and settlement of such PSUs and any Dividend Equivalent Units in strict compliance with Section 409A of the Code. Further, notwithstanding anything herein to the contrary, if at the time of the Grantee’s termination of employment with the Company, the Grantee is a “specified employee” as defined in Section 409A of the Code, and the deferral of the commencement of any payments or benefits otherwise payable hereunder as a result of such termination of service is necessary in order to prevent the imposition of any accelerated or additional tax under Section 409A of the Code, then the Company will defer the commencement of the payment of any such payments or benefits hereunder (without any reduction in such payments or benefits ultimately paid or provided to the Grantee) to the minimum extent necessary to satisfy Section 409A of the Code until the date that is six months and one day following the Grantee’s termination of employment with the Company (or the earliest date as is permitted under Section 409A of the Code), if such payment or benefit is payable upon a termination of employment. For purposes of this Agreement, a “termination of employment” shall have the same

---

meaning as “separation from service” under Section 409A of the Code and the Grantee shall be deemed to have remained employed so long as the Grantee has not “separated from service” with the Company or Successor. Each payment of PSUs (and related Dividend Equivalent Units) constitutes a “separate payment” for purposes of Section 409A of the Code.

If any provision of this Agreement is, or becomes, or is deemed to be invalid, illegal, or unenforceable in any jurisdiction or as to any Person or the Award, or would disqualify the Plan or Award under any laws deemed applicable by the Committee, such provision shall be construed or deemed amended to conform to the applicable laws, or if it cannot be construed or deemed amended without, in the determination of the Committee, materially altering the intent of the Plan or the Award, such provision shall be stricken as to such jurisdiction, Person or Award, and the remainder of the Plan and Award shall remain in full force and effect.

The validity, interpretation, construction and performance of this Agreement shall be governed by the laws of the State of Tennessee without giving effect to the conflicts of law principles thereof, except to the extent that such laws are preempted by Federal law.

This Agreement shall inure to the benefit of and be binding upon any successor to the Company. This Agreement shall inure to the benefit of the Grantee’s legal representatives. All obligations imposed upon the Grantee and all rights granted to the Company under this Agreement shall be binding upon the Grantee’s heirs, executors, administrators and successors.

Any dispute or disagreement which may arise under, or as a result of, or in any way related to, the interpretation, construction or application of this Agreement shall be determined by the Committee and shall be final, binding and conclusive on the Grantee and the Company for all purposes. In the event of any controversy among the parties hereto arising out of, or relating to, this Agreement which cannot be resolved in accordance with the foregoing, such controversy shall be finally, exclusively and conclusively settled by mandatory arbitration conducted expeditiously in accordance with the American Arbitration Association rules, by a single independent arbitrator. Such arbitration process shall take place within the Nashville, Tennessee metropolitan area. The decision of the arbitrator shall be final and binding upon all parties hereto and shall be rendered pursuant to a written decision, which contains a detailed recital of the arbitrator’s reasoning. Judgment upon the award rendered may be entered in any court having jurisdiction thereof. Each party shall bear its own legal fees and expenses, unless otherwise determined by the arbitrator. If the Grantee substantially prevails on any of his or her substantive legal claims, then the Company shall reimburse all legal fees and arbitration fees incurred by the Grantee to arbitrate the dispute.

Any notice to be given under the terms of this Agreement to the Company shall be addressed to the Company in care of its Secretary or its designee, and any notice to be given to the Grantee shall be addressed to the Grantee at the address (including an electronic address) then reflected in the Company’s books and records. By a notice given pursuant to this Section 13, either party may

---

hereafter designate a different address for notices to be given to such party. Any notice, which is required to be given to the Grantee, shall, if the Grantee is then deceased, be given to the Grantee’s personal representative if such representative has previously informed the Company of the personal representative’s status and address by written notice under this Section 13. Any notice shall have been deemed duly given when (i) delivered in person, (ii) delivered in an electronic form approved by the Company, (iii) enclosed in a properly sealed envelope or wrapper addressed as aforesaid, deposited (with postage prepaid) in a post office or branch post office regularly maintained by the United States Postal Service, or (iv) enclosed in a properly sealed envelope or wrapper addressed as aforesaid, deposited (with fees prepaid) in an office regularly maintained by FedEx, UPS, or comparable non-public mail carrier.

---

---

IN WITNESS WHEREOF, the parties have caused this Performance Share Unit Agreement to be duly executed effective as of the day and year first above written.

Genesco Inc.

 

By:

 

 

Grantee:

 

(electronically accepted)

---

Exhibit 31.1

 

CERTIFICATIONS

I, Mimi E. Vaughn, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Genesco Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: June 13, 2024

 

/s/ Mimi E. Vaughn

Mimi E. Vaughn

Chief Executive Officer

 

---

Exhibit 31.2

 

CERTIFICATIONS

I, Thomas A. George, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Genesco Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: June 13, 2024

 

/s/ Thomas A. George

Thomas A. George

Senior Vice President - Finance and Chief Financial Officer

 

---

 

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Genesco Inc. (the “Company”) on Form 10-Q for the period ending May 4, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mimi E. Vaughn, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ Mimi E. Vaughn

Mimi E. Vaughn

Chief Executive Officer

June 13, 2024

 

---

 

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Genesco Inc. (the “Company”) on Form 10-Q for the period ending May 4, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Thomas A. George, Senior Vice President - Finance and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ Thomas A. George

Thomas A. George

Senior Vice President - Finance and Chief Financial Officer

June 13, 2024

 

---

v3.24.1.1.u2

Cover Page - shares	3 Months Ended
	May 04, 2024	May 31, 2024
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	May 04, 2024
Document Transition Report	false
Entity File Number	1-3083
Entity Registrant Name	Genesco Inc
Entity Incorporation, State or Country Code	TN
Entity Tax Identification Number	62-0211340
Entity Address, Address Line One	535 Marriott Drive
Entity Address, City or Town	Nashville
Entity Address, State or Province	TN
Entity Address, Postal Zip Code	37214
City Area Code	615
Local Phone Number	367-7000
Title of 12(b) Security	Common Stock, $1.00 par value
Trading Symbol	GCO
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock Shares Outstanding		11,626,195
Entity Central Index Key	0000018498
Amendment Flag	false
Document Fiscal Year Focus	2025
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--02-01

v3.24.1.1.u2

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	May 04, 2024		Feb. 03, 2024	Apr. 29, 2023
Current Assets:
Cash	$ 19,247		$ 35,155	$ 31,786
Accounts receivable, net of allowances of $2,545 at May 4, 2024, $4,266 at January 28, 2023 and $4,051 at April 29, 2023	50,119		53,618	54,068
Inventories	392,671		378,967	470,763
Prepaids and other current assets	46,003		39,611	42,325
Total current assets	508,040		507,351	598,942
Property and equipment, net	233,601		240,266	239,120
Operating lease right of use assets	420,133		436,896	477,962
Non-current prepaid income taxes	57,441		56,839	54,567
Goodwill	9,417		9,565	37,928
Other intangibles	26,914		27,250	27,538
Deferred income taxes	26,119		26,230	28,729
Other noncurrent assets	25,752		25,493	30,526
Total Assets	1,307,417	[1]	1,329,890	1,495,312	[2]
Current Liabilities:
Accounts payable	108,847		114,621	143,814
Current portion - operating lease liabilities	125,450		129,189	131,830
Other accrued liabilities	73,888		75,727	75,992
Total current liabilities	308,185		319,537	351,636
Long-term debt	59,444		34,682	118,151
Long-term operating lease liabilities	345,670		359,073	399,374
Other long-term liabilities	45,665		45,396	43,526
Total liabilities	758,964		758,688	912,687
Commitments and contingent liabilities
Equity
Non-redeemable preferred stock	812		813	812
Common equity:
Common stock, $1 par value: Authorized; 80,000,000 shares Issued common stock	12,122		11,961	13,052
Additional paid-in capital	322,288		319,143	308,817
Retained earnings	271,647		296,766	318,538
Accumulated other comprehensive loss	(40,559)		(39,624)	(40,737)
Treasury shares, at cost (488,464 shares)	(17,857)		(17,857)	(17,857)
Total equity	548,453		571,202	582,625
Total Liabilities and Equity	$ 1,307,417		$ 1,329,890	$ 1,495,312
[1] Of our $653.7 million of long-lived assets, $90.0 million and $11.9 million relate to long-lived assets in the U.K. and Canada, respectively. [2] Of our $717.1 million of long-lived assets, $91.2 million and $15.4 million relate to long-lived assets in the U.K. and Canada, respectively.

v3.24.1.1.u2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	May 04, 2024	Feb. 03, 2024	Apr. 29, 2023
Current Assets:
Allowances on accounts receivable	$ 2,545	$ 4,266	$ 4,051
Common equity:
Common stock, par value (in dollars per share)	$ 1	$ 1	$ 1
Common stock, shares authorized (in shares)	80,000,000	80,000,000	80,000,000
Treasury Stock, Shares	488,464	488,464	488,464

v3.24.1.1.u2

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands		3 Months Ended
		May 04, 2024		Apr. 29, 2023
Income Statement [Abstract]
Net sales		$ 457,597	[1]	$ 483,332	[2]
Cost of sales		241,316		254,524
Gross margin		216,281		228,808
Selling and administrative expenses		247,831		251,497
Asset impairments and other, net	[3]	578		308
Operating loss		(32,128)		(22,997)
Other components of net periodic benefit cost		109		92
Interest expense, net		890		1,651
Loss from continuing operations before income taxes		(33,127)		(24,740)
Income tax benefit		(8,839)		(5,865)
Loss from continuing operations		(24,288)		(18,875)
Loss from discontinued operations, net of tax		(59)		(15)
Net Loss		$ (24,347)		$ (18,890)
Basic loss per common share:
Continuing operations (in dollars per share)		$ (2.22)		$ (1.6)
Discontinued operations (in dollars per share)		(0.01)		0
Net loss (in dollars per share)		(2.23)		(1.6)
Diluted loss per common share:
Continuing operations (in dollars per share)		(2.22)		(1.6)
Discontinued operations (in dollars per share)		(0.01)		0
Net loss (in dollars per share)		$ (2.23)		$ (1.6)
Weighted average shares outstanding:
Basic (in shares)		10,930		11,818
Diluted (in shares)		10,930		11,818
[1] Net sales in North America and in the U.K., which includes the ROI, accounted for 80% and 20%, respectively, of our net sales in the first quarter of Fiscal 2025 [2] Net sales in North America and in the U.K., which includes the ROI, accounted for 81% and 19%, respectively, of our net sales for the first quarter of Fiscal 2024. [3] Asset impairments and other includes a $0.3 million charge for asset impairments in Journeys Group and $0.3 million for severance.

v3.24.1.1.u2

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	May 04, 2024	Apr. 29, 2023
Statement of Comprehensive Income [Abstract]
Net Income (Loss)	$ (24,347)	$ (18,890)
Other comprehensive income (loss):
Postretirement liability adjustments, net of tax	38	29
Foreign currency translation adjustments	(973)	445
Total other comprehensive income (loss)	(935)	474
Comprehensive Loss	$ (25,282)	$ (18,416)

v3.24.1.1.u2

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	May 04, 2024	Apr. 29, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (24,347)	$ (18,890)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	13,237	11,286
Deferred income taxes	399	16
Impairment of long-lived assets	244	308
Share-based compensation expense	3,307	3,772
Other	72	315
Changes in working capital and other assets and liabilities:
Accounts receivable	3,573	(13,367)
Inventories	(14,466)	(11,789)
Prepaids and other current assets	(6,415)	(16,364)
Accounts payable	(5,816)	359
Other accrued liabilities	(2,158)	(4,843)
Other assets and liabilities	(1,374)	(11,248)
Net cash used in operating activities	(33,744)	(60,445)
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(6,377)	(17,235)
Proceeds from asset sales	0	87
Net cash used in investing activities	(6,377)	(17,148)
CASH FLOWS FROM FINANCING ACTIVITIES:
Borrowings under revolving credit facility	83,374	152,569
Payments on revolving credit facility	(58,573)	(79,469)
Shares repurchased related to share repurchase plan	0	(9,170)
Shares repurchased related to taxes for share-based awards	(773)	(449)
Change in overdraft balances	214	(1,698)
Net cash provided by financing activities	24,242	61,783
Effect of foreign exchange rate fluctuations on cash	(29)	(394)
Net decrease in cash	(15,908)	(16,204)
Cash at beginning of period	35,155	47,990
Cash at end of period	19,247	31,786
Supplemental information:
Interest paid	761	1,147
Income taxes paid	$ 1,116	$ 626

v3.24.1.1.u2

Condensed Consolidated Statements of Equity - USD ($) $ in Thousands	Total	Non-Redeemable Preferred Stock	Common Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Treasury Shares
Beginning balance at Jan. 28, 2023	$ 606,966	$ 815	$ 13,089	$ 305,260	$ 346,870	$ (41,211)	$ (17,857)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income (Loss)	(18,890)				(18,890)
Other comprehensive income (loss)	474					474
Share-based compensation expense	3,772			3,772
Restricted stock issuance	0		234	(234)
Restricted shares withheld for taxes	(449)		(13)	13	(449)
Shares repurchased	(9,170)		(255)		(8,915)
Other	(78)	(3)	(3)	6	(78)
Ending balance at Apr. 29, 2023	582,625	812	13,052	308,817	318,538	(40,737)	(17,857)
Beginning balance at Feb. 03, 2024	571,202	813	11,961	319,143	296,766	(39,624)	(17,857)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income (Loss)	(24,347)				(24,347)
Other comprehensive income (loss)	(935)					(935)
Share-based compensation expense	3,307			3,307
Restricted stock issuance	0		198	(198)
Restricted shares withheld for taxes	(773)		(29)	29	(773)
Other	(1)	(1)	(8)	7	1
Ending balance at May. 04, 2024	$ 548,453	$ 812	$ 12,122	$ 322,288	$ 271,647	$ (40,559)	$ (17,857)

v3.24.1.1.u2

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended
	May 04, 2024	Apr. 29, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ (24,347)	$ (18,890)

v3.24.1.1.u2

Insider Trading Arrangements	3 Months Ended
	May 04, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

v3.24.1.1.u2

Summary of Significant Accounting Policies	3 Months Ended
	May 04, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 1 Summary of Significant Accounting Policies Basis of Presentation These Condensed Consolidated Financial Statements should be read in conjunction with our Consolidated Financial Statements and Notes for Fiscal 2024, which are contained in our Annual Report on Form 10-K as filed with the SEC on March 27, 2024. The Condensed Consolidated Financial Statements and Notes contained in this report are unaudited but reflect all adjustments, including normal recurring adjustments, necessary for a fair presentation of the results for the interim periods of the fiscal year ending February 1, 2025 ("Fiscal 2025"), which is a 52-week year, and of the fiscal year ended February 3, 2024 ("Fiscal 2024"), which was a 53-week year. All subsidiaries are consolidated in the Condensed Consolidated Financial Statements. All significant intercompany transactions and accounts have been eliminated. The results of operations for any interim period are not necessarily indicative of results for the full year. The Condensed Consolidated Financial Statements and the related Notes have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and notes required by U.S. Generally Accepted Accounting Principles (“GAAP”) for complete financial statements. The Condensed Consolidated Balance Sheet as of February 3, 2024 has been derived from the audited financial statements at that date. Nature of Operations Genesco Inc. and its subsidiaries (collectively the "Company", "Genesco," "we", "our", or "us") business includes the sourcing and design, marketing and distribution of footwear and accessories through retail stores in the U.S., Puerto Rico and Canada primarily under the Journeys®, Journeys Kidz®, Little Burgundy® and Johnston & Murphy® banners and under the Schuh® banner in the United Kingdom (“U.K.”) and the Republic of Ireland (“ROI”); through e-commerce websites including the following: journeys.com, journeyskidz.com, journeys.ca, littleburgundyshoes.com, schuh.co.uk, schuh.ie, schuh.eu, johnstonmurphy.com, johnstonmurphy.ca, nashvilleshoewarehouse.com and dockersshoes.com as well as catalogs. We also source, design, market and distribute footwear and accessories at wholesale, primarily under our Johnston & Murphy brand, the licensed Levi's® brand, the licensed Dockers® brand, the licensed G.H. Bass® brand and other brands that we license for footwear. At May 4, 2024, we operated 1,321 retail stores in the U.S., Puerto Rico, Canada, the U.K. and the ROI. During the three months ended May 4, 2024 and April 29, 2023, we operated four reportable business segments (not including corporate): (i) Journeys Group, comprised of the Journeys, Journeys Kidz and Little Burgundy retail footwear chains and e-commerce operations; (ii) Schuh Group, comprised of the Schuh retail footwear chain and e-commerce operations; (iii) Johnston & Murphy Group, comprised of Johnston & Murphy retail operations, e-commerce operations and wholesale distribution of products under the Johnston & Murphy brand; and (iv) Genesco Brands Group, comprised of the licensed Dockers, Levi's, and G.H. Bass brands, as well as other brands we license for footwear. Selling and Administrative Expenses Wholesale costs of distribution are included in selling and administrative expenses on the Condensed Consolidated Statements of Operations in the amount of $2.4 million and $3.5 million for the first quarters of Fiscal 2025 and Fiscal 2024, respectively. Retail occupancy costs recorded in selling and administrative expenses were $75.5 million and $76.4 million for the first quarters of Fiscal 2025 and Fiscal 2024, respectively.   Advertising Costs Advertising costs were $23.7 million and $23.6 million for the first quarters of Fiscal 2025 and Fiscal 2024, respectively. Vendor Allowances Vendor reimbursements of cooperative advertising costs recognized as a reduction of selling and administrative expenses were $1.9 million and $4.7 million for the first quarters of Fiscal 2025 and Fiscal 2024, respectively. During the first three months of each of Fiscal 2025 and Fiscal 2024, our cooperative advertising reimbursements received were not in excess of the costs incurred.   Note 1 Summary of Significant Accounting Policies, Continued New Accounting Pronouncements We continuously monitor and review all current accounting pronouncements and standards from the FASB of U.S. GAAP for applicability to our operations and financial reporting. As of May 4, 2024, there were no other new pronouncements or interpretations, other than those disclosed in the Annual Report on Form 10-K for the fiscal year ended February 3, 2024, that had or were expected to have a significant impact on our financial reporting.

v3.24.1.1.u2

Goodwill and Other Intangible Assets	3 Months Ended
	May 04, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	Note 2 Goodwill and Other Intangible Assets The changes in the carrying amount of goodwill for the Journeys Group segment were as follows:   (In thousands) Total Goodwill   Balance, February 3, 2024 $ 9,565   Effect of foreign currency exchange rates   (148 ) Balance, May 4, 2024 $ 9,417   Other intangibles by major classes were as follows:       Trademarks   Customer Lists     Other     Total   (In thousands)   May 4, 2024     Feb. 3, 2024   May 4, 2024     Feb. 3, 2024     May 4, 2024     Feb. 3, 2024     May 4, 2024     Feb. 3, 2024   Gross other intangibles   $ 24,270     $ 24,464   $ 6,490     $ 6,501     $ 400     $ 400     $ 31,160     $ 31,365   Accumulated amortization     —       —     (3,846 )     (3,715 )     (400 )     (400 )     (4,246 )     (4,115 ) Net Other Intangibles   $ 24,270     $ 24,464   $ 2,644     $ 2,786     $ —     $ —     $ 26,914     $ 27,250

v3.24.1.1.u2

Inventories	3 Months Ended
	May 04, 2024
Inventory Disclosure [Abstract]
Inventories	Note 3 Inventories     (In thousands)   May 4, 2024     February 3, 2024   Wholesale finished goods   $ 44,268     $ 57,678   Retail merchandise     348,403       321,289   Total Inventories   $ 392,671     $ 378,967

v3.24.1.1.u2

Fair Value	3 Months Ended
	May 04, 2024
Fair Value Disclosures [Abstract]
Fair Value	Note 4 Fair Value Fair Value of Financial Instruments The carrying amounts and fair values of our financial instruments at May 4, 2024 and February 3, 2024 are:         (In thousands) May 4, 2024   February 3, 2024     Carrying Amount   Fair Value   Carrying Amount   Fair Value   U.S. Revolver Borrowings $ 59,444   $ 59,595   $ 34,682   $ 34,638   Total Long-Term Debt $ 59,444   $ 59,595   $ 34,682   $ 34,638     Debt fair values were determined using a discounted cash flow analysis based on current market interest rates for similar types of financial instruments and would be classified in Level 2 within the fair value hierarchy. We did not have any debt classified as current portion as of May 4, 2024 or February 3, 2024.   As of May 4, 2024, we have $0.7 million of long-lived assets held and used which were measured using Level 3 inputs within the fair value hierarchy. As of May 4, 2024, we have $6.5 million of investments held and used which were measured using Level 1 inputs within the fair value hierarchy.

v3.24.1.1.u2

Long-Term Debt	3 Months Ended
	May 04, 2024
Debt Disclosure [Abstract]
Long-Term Debt	Note 5 Long-Term Debt   The revolver borrowings outstanding under the Credit Facility as of May 4, 2024 included $56.3 million U.S. revolver borrowings and $3.1 million (C$4.3 million) related to GCO Canada ULC. We were in compliance with all the relevant terms and conditions of the Credit Facility and Facility Agreement as of May 4, 2024. Excess availability under the Credit Facility was $200.1 million at May 4, 2024.

v3.24.1.1.u2

Earnings Per Share	3 Months Ended
	May 04, 2024
Earnings Per Share [Abstract]
Earnings Per Share	Note 6 Earnings Per Share Weighted-average number of shares used to calculate earnings per share are as follows:       Three Months Ended   (Shares in thousands)   May 4, 2024     April 29, 2023   Weighted-average number of shares - basic     10,930       11,818   Common stock equivalents     -       -   Weighted-average number of shares - diluted     10,930       11,818   Common stock equivalents of 0.2 million shares are excluded for each of the three months ended May 4, 2024 and April 29, 2023 due to the loss from continuing operations because to do so would be anti-dilutive. We did not repurchase any shares during the first quarter of Fiscal 2025. We have $52.1 million remaining as of May 4, 2024 under our expanded share repurchase authorization announced in June 2023. We repurchased 255,000 shares during the first quarter of Fiscal 2024 at a cost of $9.2 million, or $35.96 per share. During the second quarter of Fiscal 2025, through June 12, 2024, we have repurchased 7,700 shares at a cost of $0.2 million, or $24.90 per share.

v3.24.1.1.u2

Legal Proceedings	3 Months Ended
	May 04, 2024
Commitments and Contingencies Disclosure [Abstract]
Legal Proceedings	Note 7 Legal Proceedings Environmental Matters The Company has legacy obligations including environmental monitoring and reporting costs related to: (i) a 2016 Consent Judgment entered into with the United States Environmental Protection Agency involving the site of a knitting mill operated by a former subsidiary from 1965 to 1969 in Garden City, New York; and (ii) a 2010 Consent Decree with the Michigan Department of Natural Resources and Environment relating to our former Volunteer Leather Company facility in Whitehall, Michigan. We do not expect that future obligations related to either of these sites will have a material effect on our consolidated financial condition or results of operations.   Accrual for Environmental Contingencies Related to all outstanding environmental contingencies, we had accrued $2.0 million as of May 4, 2024, $2.0 million as of February 3, 2024 and $1.7 million as of April 29, 2023. All such provisions reflect our estimates of the most likely cost (undiscounted, including both current and noncurrent portions) of resolving the contingencies, based on facts and circumstances as of the time they were made. There is no assurance that relevant facts and circumstances will not change, necessitating future changes to the provisions. Such contingent liabilities for discontinued operations are included in other accrued liabilities and other long-term liabilities on the accompanying Condensed Consolidated Balance Sheets because they relate to former facilities operated by us. We have made pretax accruals for certain of these contingencies which were not material for the first quarter of Fiscal 2025 or Fiscal 2024. These charges are included in loss from discontinued operations, net of tax in the Condensed Consolidated Statements of Operations and represent changes in estimates. In addition to the matters specifically described in this Note, we are a party to other legal and regulatory proceedings and claims arising in the ordinary course of our business. While management does not believe that our liability with respect to any of these other matters is likely to have a material effect on our condensed consolidated financial statements, legal proceedings are subject to inherent uncertainties, and unfavorable rulings could have a material adverse impact on our condensed consolidated financial statements.

v3.24.1.1.u2

Commitments	3 Months Ended
	May 04, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments	Note 8 Commitments   As part of our Genesco Brands Group business, we have a commitment to Samsung C&T America, Inc. (“Samsung”) related to the ultimate sale and valuation of any inventories owned by Samsung. If product is sold below Samsung’s cost, we are required to pay to Samsung the difference between the sales price and its cost. At May 4, 2024, the inventory owned by Samsung had a historical cost of $7.8 million. As of May 4, 2024, we believe that we have appropriately accounted for any differences between the fair value of the Samsung inventory and Samsung's historical cost.

v3.24.1.1.u2

Business Segment Information	3 Months Ended
	May 04, 2024
Segment Reporting [Abstract]
Business Segment Information	Note 9 Business Segment Information   Three Months Ended May 4, 2024                         (In thousands) Journeys Group   Schuh Group   Johnston & Murphy Group   Genesco Brands Group   Corporate & Other   Consolidated   Sales $ 259,445   $ 92,349   $ 79,207   $ 28,593   $ —   $ 459,594   Intercompany sales   —     —     —     (1,997 )   —     (1,997 ) Net sales to external customers(1)   259,445     92,349     79,207     26,596     —     457,597   Segment operating income (loss)   (18,822 )   (5,896 )   2,355     (986 )   (8,201 )   (31,550 ) Asset impairments and other(2)   —     —     —     —     578     578   Operating income (loss)   (18,822 )   (5,896 )   2,355     (986 )   (8,779 )   (32,128 ) Other components of net periodic benefit cost   —     —     —     —     109     109   Interest expense, net   —     —     —     —     890     890   Earnings (loss) from continuing operations before income taxes $ (18,822 ) $ (5,896 ) $ 2,355   $ (986 ) $ (9,778 ) $ (33,127 ) Total assets (3) $ 653,489   $ 209,372   $ 153,890   $ 54,716   $ 235,950   $ 1,307,417   Depreciation and amortization   8,612     1,869     1,382     314     1,060     13,237   Capital expenditures   3,491     733     1,715     231     207     6,377     (1) Net sales in North America and in the U.K., which includes the ROI, accounted for 80% and 20%, respectively, of our net sales in the first quarter of Fiscal 2025. (2) Asset impairments and other includes a $0.3 million charge for asset impairments in Journeys Group and $0.3 million for severance. (3) Of our $653.7 million of long-lived assets, $90.0 million and $11.9 million relate to long-lived assets in the U.K. and Canada, respectively.   Three Months Ended April 29, 2023                         (In thousands) Journeys Group   Schuh Group   Johnston & Murphy Group   Genesco Brands Group   Corporate & Other   Consolidated   Sales $ 272,190   $ 93,105   $ 82,630   $ 35,864   $ —   $ 483,789   Intercompany sales   —     —     (3 )   (454 )   —     (457 ) Net sales to external customers(1)   272,190     93,105     82,627     35,410     —     483,332   Segment operating income (loss)   (18,362 )   (1,790 )   4,806     (32 )   (7,311 )   (22,689 ) Asset impairments and other (2)   —     —     —     —     308     308   Operating income (loss)   (18,362 )   (1,790 )   4,806     (32 )   (7,619 )   (22,997 ) Other components of net periodic benefit cost   —     —     —     —     92     92   Interest expense, net   —     —     —     —     1,651     1,651   Earnings (loss) from continuing operations before income taxes $ (18,362 ) $ (1,790 ) $ 4,806   $ (32 ) $ (9,362 ) $ (24,740 ) Total assets (3) $ 765,064   $ 212,579   $ 187,247   $ 78,313   $ 252,109   $ 1,495,312   Depreciation and amortization   7,347     1,561     1,120     203     1,055     11,286   Capital expenditures   13,019     2,151     1,205     455     405     17,235     (1) Net sales in North America and in the U.K., which includes the ROI, accounted for 81% and 19%, respectively, of our net sales for the first quarter of Fiscal 2024. (2) Asset impairments and other includes a $0.3 million charge for asset impairments in Journeys Group. (3) Of our $717.1 million of long-lived assets, $91.2 million and $15.4 million relate to long-lived assets in the U.K. and Canada, respectively.

v3.24.1.1.u2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	May 04, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation These Condensed Consolidated Financial Statements should be read in conjunction with our Consolidated Financial Statements and Notes for Fiscal 2024, which are contained in our Annual Report on Form 10-K as filed with the SEC on March 27, 2024. The Condensed Consolidated Financial Statements and Notes contained in this report are unaudited but reflect all adjustments, including normal recurring adjustments, necessary for a fair presentation of the results for the interim periods of the fiscal year ending February 1, 2025 ("Fiscal 2025"), which is a 52-week year, and of the fiscal year ended February 3, 2024 ("Fiscal 2024"), which was a 53-week year. All subsidiaries are consolidated in the Condensed Consolidated Financial Statements. All significant intercompany transactions and accounts have been eliminated. The results of operations for any interim period are not necessarily indicative of results for the full year. The Condensed Consolidated Financial Statements and the related Notes have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and notes required by U.S. Generally Accepted Accounting Principles (“GAAP”) for complete financial statements. The Condensed Consolidated Balance Sheet as of February 3, 2024 has been derived from the audited financial statements at that date.
Nature of Operations	Nature of Operations Genesco Inc. and its subsidiaries (collectively the "Company", "Genesco," "we", "our", or "us") business includes the sourcing and design, marketing and distribution of footwear and accessories through retail stores in the U.S., Puerto Rico and Canada primarily under the Journeys®, Journeys Kidz®, Little Burgundy® and Johnston & Murphy® banners and under the Schuh® banner in the United Kingdom (“U.K.”) and the Republic of Ireland (“ROI”); through e-commerce websites including the following: journeys.com, journeyskidz.com, journeys.ca, littleburgundyshoes.com, schuh.co.uk, schuh.ie, schuh.eu, johnstonmurphy.com, johnstonmurphy.ca, nashvilleshoewarehouse.com and dockersshoes.com as well as catalogs. We also source, design, market and distribute footwear and accessories at wholesale, primarily under our Johnston & Murphy brand, the licensed Levi's® brand, the licensed Dockers® brand, the licensed G.H. Bass® brand and other brands that we license for footwear. At May 4, 2024, we operated 1,321 retail stores in the U.S., Puerto Rico, Canada, the U.K. and the ROI. During the three months ended May 4, 2024 and April 29, 2023, we operated four reportable business segments (not including corporate): (i) Journeys Group, comprised of the Journeys, Journeys Kidz and Little Burgundy retail footwear chains and e-commerce operations; (ii) Schuh Group, comprised of the Schuh retail footwear chain and e-commerce operations; (iii) Johnston & Murphy Group, comprised of Johnston & Murphy retail operations, e-commerce operations and wholesale distribution of products under the Johnston & Murphy brand; and (iv) Genesco Brands Group, comprised of the licensed Dockers, Levi's, and G.H. Bass brands, as well as other brands we license for footwear.
Selling and Administrative Expenses	Selling and Administrative Expenses Wholesale costs of distribution are included in selling and administrative expenses on the Condensed Consolidated Statements of Operations in the amount of $2.4 million and $3.5 million for the first quarters of Fiscal 2025 and Fiscal 2024, respectively. Retail occupancy costs recorded in selling and administrative expenses were $75.5 million and $76.4 million for the first quarters of Fiscal 2025 and Fiscal 2024, respectively.
Advertising Costs	Advertising Costs Advertising costs were $23.7 million and $23.6 million for the first quarters of Fiscal 2025 and Fiscal 2024, respectively.
Vendor Allowances	Vendor Allowances Vendor reimbursements of cooperative advertising costs recognized as a reduction of selling and administrative expenses were $1.9 million and $4.7 million for the first quarters of Fiscal 2025 and Fiscal 2024, respectively. During the first three months of each of Fiscal 2025 and Fiscal 2024, our cooperative advertising reimbursements received were not in excess of the costs incurred.
New Accounting Pronouncements	New Accounting Pronouncements We continuously monitor and review all current accounting pronouncements and standards from the FASB of U.S. GAAP for applicability to our operations and financial reporting. As of May 4, 2024, there were no other new pronouncements or interpretations, other than those disclosed in the Annual Report on Form 10-K for the fiscal year ended February 3, 2024, that had or were expected to have a significant impact on our financial reporting.

v3.24.1.1.u2

Goodwill and Other Intangible Assets (Tables)	3 Months Ended
	May 04, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of Changes in Carrying Amount for the Journeys Group Segment	The changes in the carrying amount of goodwill for the Journeys Group segment were as follows:   (In thousands) Total Goodwill   Balance, February 3, 2024 $ 9,565   Effect of foreign currency exchange rates   (148 ) Balance, May 4, 2024 $ 9,417
Summary of Other Intangible Assets	Other intangibles by major classes were as follows:       Trademarks   Customer Lists     Other     Total   (In thousands)   May 4, 2024     Feb. 3, 2024   May 4, 2024     Feb. 3, 2024     May 4, 2024     Feb. 3, 2024     May 4, 2024     Feb. 3, 2024   Gross other intangibles   $ 24,270     $ 24,464   $ 6,490     $ 6,501     $ 400     $ 400     $ 31,160     $ 31,365   Accumulated amortization     —       —     (3,846 )     (3,715 )     (400 )     (400 )     (4,246 )     (4,115 ) Net Other Intangibles   $ 24,270     $ 24,464   $ 2,644     $ 2,786     $ —     $ —     $ 26,914     $ 27,250

v3.24.1.1.u2

Inventories (Tables)	3 Months Ended
	May 04, 2024
Inventory Disclosure [Abstract]
Schedule of Inventories	(In thousands)   May 4, 2024     February 3, 2024   Wholesale finished goods   $ 44,268     $ 57,678   Retail merchandise     348,403       321,289   Total Inventories   $ 392,671     $ 378,967

v3.24.1.1.u2

Fair Value (Tables)	3 Months Ended
	May 04, 2024
Fair Value Disclosures [Abstract]
Schedule of Fair Values of Financial Instruments	The carrying amounts and fair values of our financial instruments at May 4, 2024 and February 3, 2024 are:         (In thousands) May 4, 2024   February 3, 2024     Carrying Amount   Fair Value   Carrying Amount   Fair Value   U.S. Revolver Borrowings $ 59,444   $ 59,595   $ 34,682   $ 34,638   Total Long-Term Debt $ 59,444   $ 59,595   $ 34,682   $ 34,638

v3.24.1.1.u2

Earnings Per Share (Tables)	3 Months Ended
	May 04, 2024
Earnings Per Share [Abstract]
Summary of Weighted-Average Number of Shares	Weighted-average number of shares used to calculate earnings per share are as follows:       Three Months Ended   (Shares in thousands)   May 4, 2024     April 29, 2023   Weighted-average number of shares - basic     10,930       11,818   Common stock equivalents     -       -   Weighted-average number of shares - diluted     10,930       11,818

v3.24.1.1.u2

Business Segment Information (Tables)	3 Months Ended
	May 04, 2024
Segment Reporting [Abstract]
Schedule of Business Segment Information	Three Months Ended May 4, 2024                         (In thousands) Journeys Group   Schuh Group   Johnston & Murphy Group   Genesco Brands Group   Corporate & Other   Consolidated   Sales $ 259,445   $ 92,349   $ 79,207   $ 28,593   $ —   $ 459,594   Intercompany sales   —     —     —     (1,997 )   —     (1,997 ) Net sales to external customers(1)   259,445     92,349     79,207     26,596     —     457,597   Segment operating income (loss)   (18,822 )   (5,896 )   2,355     (986 )   (8,201 )   (31,550 ) Asset impairments and other(2)   —     —     —     —     578     578   Operating income (loss)   (18,822 )   (5,896 )   2,355     (986 )   (8,779 )   (32,128 ) Other components of net periodic benefit cost   —     —     —     —     109     109   Interest expense, net   —     —     —     —     890     890   Earnings (loss) from continuing operations before income taxes $ (18,822 ) $ (5,896 ) $ 2,355   $ (986 ) $ (9,778 ) $ (33,127 ) Total assets (3) $ 653,489   $ 209,372   $ 153,890   $ 54,716   $ 235,950   $ 1,307,417   Depreciation and amortization   8,612     1,869     1,382     314     1,060     13,237   Capital expenditures   3,491     733     1,715     231     207     6,377     (1) Net sales in North America and in the U.K., which includes the ROI, accounted for 80% and 20%, respectively, of our net sales in the first quarter of Fiscal 2025. (2) Asset impairments and other includes a $0.3 million charge for asset impairments in Journeys Group and $0.3 million for severance. (3) Of our $653.7 million of long-lived assets, $90.0 million and $11.9 million relate to long-lived assets in the U.K. and Canada, respectively.   Three Months Ended April 29, 2023                         (In thousands) Journeys Group   Schuh Group   Johnston & Murphy Group   Genesco Brands Group   Corporate & Other   Consolidated   Sales $ 272,190   $ 93,105   $ 82,630   $ 35,864   $ —   $ 483,789   Intercompany sales   —     —     (3 )   (454 )   —     (457 ) Net sales to external customers(1)   272,190     93,105     82,627     35,410     —     483,332   Segment operating income (loss)   (18,362 )   (1,790 )   4,806     (32 )   (7,311 )   (22,689 ) Asset impairments and other (2)   —     —     —     —     308     308   Operating income (loss)   (18,362 )   (1,790 )   4,806     (32 )   (7,619 )   (22,997 ) Other components of net periodic benefit cost   —     —     —     —     92     92   Interest expense, net   —     —     —     —     1,651     1,651   Earnings (loss) from continuing operations before income taxes $ (18,362 ) $ (1,790 ) $ 4,806   $ (32 ) $ (9,362 ) $ (24,740 ) Total assets (3) $ 765,064   $ 212,579   $ 187,247   $ 78,313   $ 252,109   $ 1,495,312   Depreciation and amortization   7,347     1,561     1,120     203     1,055     11,286   Capital expenditures   13,019     2,151     1,205     455     405     17,235     (1) Net sales in North America and in the U.K., which includes the ROI, accounted for 81% and 19%, respectively, of our net sales for the first quarter of Fiscal 2024. (2) Asset impairments and other includes a $0.3 million charge for asset impairments in Journeys Group. (3) Of our $717.1 million of long-lived assets, $91.2 million and $15.4 million relate to long-lived assets in the U.K. and Canada, respectively.

v3.24.1.1.u2

Summary of Significant Accounting Policies - Additional Information (Details) $ in Thousands	3 Months Ended
	May 04, 2024 USD ($) Store Segment	Apr. 29, 2023 USD ($) Segment
Summary of Accounting Policies [Line Items]
Number of retail stores operated by company | Store	1,321
Number of reportable business segments | Segment	4	4
Selling and administrative expenses	$ 247,831	$ 251,497
Advertising costs	23,700	23,600
Vendor reimbursements of cooperative advertising costs	1,900	4,700
Wholesale Costs of Distribution
Summary of Accounting Policies [Line Items]
Selling and administrative expenses	2,400	3,500
Retail Occupancy Costs
Summary of Accounting Policies [Line Items]
Selling and administrative expenses	$ 75,500	$ 76,400

v3.24.1.1.u2

Goodwill and Other Intangible Assets - Summary of Changes in Carrying Amount for the Journeys Group Segment (Details) $ in Thousands	3 Months Ended
	May 04, 2024 USD ($)
Goodwill [Roll Forward]
Goodwill, beginning balance	$ 9,565
Effect of foreign currency exchange rates	(148)
Goodwill, ending balance	$ 9,417

v3.24.1.1.u2

Goodwill and Other Intangible Assets - Summary of Other Intangibles Assets (Details) - USD ($) $ in Thousands	May 04, 2024	Feb. 03, 2024	Apr. 29, 2023
Other intangibles by major classes
Gross other intangibles	$ 31,160	$ 31,365
Accumulated amortization	(4,246)	(4,115)
Net Other Intangibles	26,914	27,250	$ 27,538
Trademarks
Other intangibles by major classes
Gross other intangibles	24,270	24,464
Accumulated amortization	0	0
Net Other Intangibles	24,270	24,464
Customer Lists
Other intangibles by major classes
Gross other intangibles	6,490	6,501
Accumulated amortization	(3,846)	(3,715)
Net Other Intangibles	2,644	2,786
Other
Other intangibles by major classes
Gross other intangibles	400	400
Accumulated amortization	(400)	(400)
Net Other Intangibles	$ 0	$ 0

v3.24.1.1.u2

Asset Impairments and Other Charges - Additional Information (Details) - USD ($) $ in Thousands		3 Months Ended
		May 04, 2024	Apr. 29, 2023
Restructuring Cost And Reserve [Line Items]
Asset impairments and other, net	[1]	$ (578)	$ (308)
[1] Asset impairments and other includes a $0.3 million charge for asset impairments in Journeys Group and $0.3 million for severance.

v3.24.1.1.u2

Inventories - Schedule of Inventories (Details) - USD ($) $ in Thousands	May 04, 2024	Feb. 03, 2024	Apr. 29, 2023
Inventories
Wholesale finished goods	$ 44,268	$ 57,678
Retail merchandise	348,403	321,289
Total Inventories	$ 392,671	$ 378,967	$ 470,763

v3.24.1.1.u2

Fair Value - Schedule of Fair Values of Financial Instruments (Details) - USD ($) $ in Thousands	May 04, 2024	Feb. 03, 2024
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Amount	$ 59,444	$ 34,682
Fair Value	59,595	34,638
U.S. Revolver Borrowings
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Amount	59,444	34,682
Fair Value	$ 59,595	$ 34,638

v3.24.1.1.u2

Fair Value - Additional Information (Details) - USD ($) $ in Millions	May 04, 2024	Apr. 29, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-lived assets	$ 653.7	$ 717.1
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-lived assets	0.7
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments held	$ 6.5

v3.24.1.1.u2

Long-Term Debt - Additional Information (Details) $ in Thousands, $ in Millions	3 Months Ended
	May 04, 2024 USD ($)	May 04, 2024 CAD ($)	Feb. 03, 2024 USD ($)
Debt Instrument [Line Items]
Carrying Amount	$ 59,444		$ 34,682
Long term debt description	The revolver borrowings outstanding under the Credit Facility as of May 4, 2024 included $56.3 million U.S. revolver borrowings and $3.1 million (C$4.3 million) related to GCO Canada ULC. We were in compliance with all the relevant terms and conditions of the Credit Facility and Facility Agreement as of May 4, 2024. Excess availability under the Credit Facility was $200.1 million at May 4, 2024.
Revolving Credit Facility
Debt Instrument [Line Items]
Excess availability under credit facility	$ 200,100
Genesco Canada Ulc | Revolving Credit Facility
Debt Instrument [Line Items]
Carrying Amount	3,100	$ 4.3
U.S. Revolver Borrowings
Debt Instrument [Line Items]
Carrying Amount	59,444		$ 34,682
U.S. Revolver Borrowings | Revolving Credit Facility
Debt Instrument [Line Items]
Carrying Amount	$ 56,300

v3.24.1.1.u2

Earnings Per Share - Summary of Weighted-Average Number of Shares (Details) - shares shares in Thousands	3 Months Ended
	May 04, 2024	Apr. 29, 2023
Earnings Per Share [Abstract]
Weighted-average number of shares - basic (in shares)	10,930	11,818
Common stock equivalents (in shares)	0	0
Weighted-average number of shares - diluted (in shares)	10,930	11,818

v3.24.1.1.u2

Earnings Per Share - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	3 Months Ended
	Jun. 12, 2024	May 04, 2024	Apr. 29, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common stock equivalents excluded		0.2	0.2
Stock repurchased during period (in shares)		0	255,000
Shares repurchased			$ 9,170
Share price			$ 35.96
Remaining authorized repurchase amount		$ 52,100
Subsequent Event [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Stock repurchased during period (in shares)	7,700
Shares repurchased	$ 200
Share price	$ 24.9

v3.24.1.1.u2

Legal Proceedings - Additional Information (Details) - USD ($) $ in Millions	May 04, 2024	Feb. 03, 2024	Apr. 29, 2023
Loss Contingencies [Line Items]
Environmental Loss Contingency, Statement of Financial Position [Extensible Enumeration]	Other Accrued Liabilities, Current	Other Accrued Liabilities, Current	Other Accrued Liabilities, Current
Amount related to outstanding environmental contingencies	$ 2.0	$ 2.0	$ 1.7

v3.24.1.1.u2

Commitments - Additional Information (Details) $ in Millions	May 04, 2024 USD ($)
Samsung
Loss Contingencies [Line Items]
Historical cost of inventory	$ 7.8

v3.24.1.1.u2

Business Segment Information - Schedule of Business Segment Information (Details) - USD ($) $ in Thousands		3 Months Ended
		May 04, 2024		Apr. 29, 2023		Feb. 03, 2024
Segment Reporting Information [Line Items]
Net sales		$ 457,597	[1]	$ 483,332	[2]
Segment operating income (loss)		(31,550)		(22,689)
Asset impairments and other	[3]	578		308
Operating loss		(32,128)		(22,997)
Other components of net periodic benefit cost		109		92
Interest expense, net		890		1,651
Loss from continuing operations before income taxes		(33,127)		(24,740)
Total assets		1,307,417	[4]	1,495,312	[5]	$ 1,329,890
Depreciation and amortization		13,237		11,286
Capital expenditures		6,377		17,235
Journeys Group
Segment Reporting Information [Line Items]
Net sales		259,445	[1]	272,190	[2]
Schuh Group
Segment Reporting Information [Line Items]
Net sales		92,349	[1]	93,105	[2]
Johnston & Murphy Group
Segment Reporting Information [Line Items]
Net sales		79,207	[1]	82,627	[2]
Genesco Brands Group
Segment Reporting Information [Line Items]
Net sales		26,596	[1]	35,410	[2]
Operating Segments
Segment Reporting Information [Line Items]
Net sales		459,594		483,789
Operating Segments | Journeys Group
Segment Reporting Information [Line Items]
Net sales		259,445		272,190
Segment operating income (loss)		(18,822)		(18,362)
Asset impairments and other		0	[3]	0	[6]
Operating loss		(18,822)		(18,362)
Other components of net periodic benefit cost		0		0
Interest expense, net		0		0
Loss from continuing operations before income taxes		(18,822)		(18,362)
Total assets		653,489	[4]	765,064	[5]
Depreciation and amortization		8,612		7,347
Capital expenditures		3,491		13,019
Operating Segments | Schuh Group
Segment Reporting Information [Line Items]
Net sales		92,349		93,105
Segment operating income (loss)		(5,896)		(1,790)
Asset impairments and other	[3]	0		0
Operating loss		(5,896)		(1,790)
Other components of net periodic benefit cost		0		0
Interest expense, net		0		0
Loss from continuing operations before income taxes		(5,896)		(1,790)
Total assets		209,372	[4]	212,579	[5]
Depreciation and amortization		1,869		1,561
Capital expenditures		733		2,151
Operating Segments | Johnston & Murphy Group
Segment Reporting Information [Line Items]
Net sales		79,207		82,630
Segment operating income (loss)		2,355		4,806
Asset impairments and other	[3]	0		0
Operating loss		2,355		4,806
Other components of net periodic benefit cost		0		0
Interest expense, net		0		0
Loss from continuing operations before income taxes		2,355		4,806
Total assets		153,890	[4]	187,247	[5]
Depreciation and amortization		1,382		1,120
Capital expenditures		1,715		1,205
Operating Segments | Genesco Brands Group
Segment Reporting Information [Line Items]
Net sales		28,593		35,864
Segment operating income (loss)		(986)		(32)
Asset impairments and other	[3]	0		0
Operating loss		(986)		(32)
Other components of net periodic benefit cost		0		0
Interest expense, net		0		0
Loss from continuing operations before income taxes		(986)		(32)
Total assets		54,716	[4]	78,313	[5]
Depreciation and amortization		314		203
Capital expenditures		231		455
Corporate & Other
Segment Reporting Information [Line Items]
Net sales		0	[1]	0	[2]
Segment operating income (loss)		(8,201)		(7,311)
Asset impairments and other	[3]	578		308
Operating loss		(8,779)		(7,619)
Other components of net periodic benefit cost		109		92
Interest expense, net		890		1,651
Loss from continuing operations before income taxes		(9,778)		(9,362)
Total assets		235,950	[4]	252,109	[5]
Depreciation and amortization		1,060		1,055
Capital expenditures		207		405
Intercompany Sales
Segment Reporting Information [Line Items]
Net sales		(1,997)		(457)
Intercompany Sales | Journeys Group
Segment Reporting Information [Line Items]
Net sales		0		0
Intercompany Sales | Schuh Group
Segment Reporting Information [Line Items]
Net sales		0		0
Intercompany Sales | Johnston & Murphy Group
Segment Reporting Information [Line Items]
Net sales		0		(3)
Intercompany Sales | Genesco Brands Group
Segment Reporting Information [Line Items]
Net sales		$ (1,997)		$ (454)
[1] Net sales in North America and in the U.K., which includes the ROI, accounted for 80% and 20%, respectively, of our net sales in the first quarter of Fiscal 2025 [2] Net sales in North America and in the U.K., which includes the ROI, accounted for 81% and 19%, respectively, of our net sales for the first quarter of Fiscal 2024. [3] Asset impairments and other includes a $0.3 million charge for asset impairments in Journeys Group and $0.3 million for severance. [4] Of our $653.7 million of long-lived assets, $90.0 million and $11.9 million relate to long-lived assets in the U.K. and Canada, respectively. [5] Of our $717.1 million of long-lived assets, $91.2 million and $15.4 million relate to long-lived assets in the U.K. and Canada, respectively. [6] Asset impairments and other includes a $0.3 million charge for asset impairments in Journeys Group

v3.24.1.1.u2

Business Segment Information - Schedule of Business Segment Information (Parenthetical) (Details) - USD ($) $ in Thousands		3 Months Ended
		May 04, 2024	Apr. 29, 2023
Segment Reporting Information [Line Items]
Asset impairments and other, net	[1]	$ 578	$ 308
Long-lived assets		653,700	717,100
Segment operating income (loss)		(31,550)	(22,689)
U.K.
Segment Reporting Information [Line Items]
Long-lived assets		90,000	91,200
Canada
Segment Reporting Information [Line Items]
Long-lived assets		$ 11,900	$ 15,400
GeographicConcentrationRiskMember | SalesRevenueNetMember | U.K.
Segment Reporting Information [Line Items]
ConcentrationRiskPercentage1		20.00%	19.00%
GeographicConcentrationRiskMember | SalesRevenueNetMember | NorthAmerica
Segment Reporting Information [Line Items]
ConcentrationRiskPercentage1		80.00%	81.00%
Retail Store Asset Impairments | Journeys Group
Segment Reporting Information [Line Items]
Asset impairments and other, net		$ 300	$ 300
Employee Severance
Segment Reporting Information [Line Items]
Asset impairments and other, net		$ 300
[1] Asset impairments and other includes a $0.3 million charge for asset impairments in Journeys Group and $0.3 million for severance.

---